Fortress Biotech Inc (FBIO)
1.75
-0.05
(-2.78%)
USD |
NASDAQ |
May 03, 16:00
1.76
+0.01
(+0.57%)
After-Hours: 20:00
Fortress Biotech Total Return Level: 1.75 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 1.75 |
May 02, 2024 | 1.80 |
May 01, 2024 | 1.74 |
April 30, 2024 | 1.67 |
April 29, 2024 | 1.72 |
April 26, 2024 | 1.72 |
April 25, 2024 | 1.72 |
April 24, 2024 | 1.79 |
April 23, 2024 | 1.81 |
April 22, 2024 | 1.75 |
April 19, 2024 | 1.75 |
April 18, 2024 | 1.81 |
April 17, 2024 | 1.77 |
April 16, 2024 | 1.76 |
April 15, 2024 | 1.82 |
April 12, 2024 | 1.80 |
April 11, 2024 | 1.82 |
April 10, 2024 | 1.91 |
April 09, 2024 | 1.89 |
April 08, 2024 | 1.90 |
April 05, 2024 | 1.87 |
April 04, 2024 | 1.87 |
April 03, 2024 | 1.92 |
April 02, 2024 | 1.93 |
April 01, 2024 | 1.99 |
Date | Value |
---|---|
March 28, 2024 | 2.00 |
March 27, 2024 | 2.17 |
March 26, 2024 | 1.93 |
March 25, 2024 | 1.91 |
March 22, 2024 | 1.935 |
March 21, 2024 | 1.97 |
March 20, 2024 | 1.91 |
March 19, 2024 | 1.895 |
March 18, 2024 | 1.92 |
March 15, 2024 | 1.935 |
March 14, 2024 | 1.68 |
March 13, 2024 | 1.82 |
March 12, 2024 | 1.925 |
March 11, 2024 | 2.00 |
March 08, 2024 | 2.10 |
March 07, 2024 | 2.07 |
March 06, 2024 | 2.215 |
March 05, 2024 | 2.27 |
March 04, 2024 | 2.29 |
March 01, 2024 | 2.43 |
February 29, 2024 | 2.08 |
February 28, 2024 | 2.18 |
February 27, 2024 | 1.98 |
February 26, 2024 | 1.85 |
February 23, 2024 | 1.74 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.31
Minimum
Nov 10 2023
82.20
Maximum
Apr 12 2021
27.17
Average
24.00
Median
May 13 2019
Total Return Level Benchmarks
Journey Medical Corp | 3.69 |
Avenue Therapeutics Inc | 4.78 |
Mustang Bio Inc | 0.3178 |
Checkpoint Therapeutics Inc | 1.58 |
Viking Therapeutics Inc | 76.97 |